Company profile
Esperante | Specialising in innovative life science investments
A corporate venture investment company focussed on investing in mid to late stage clinical stage therapeutics development companies in North America and Europe
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
CH01 | Transaction MzUxNDA3MjYzNGFkaXF6a2N4
Published 04 Apr 2026 06:21
Last accounts made up date
TM01 | Transaction MzQzODkxMzA2NGFkaXF6a2N4
Published 09 Oct 2024 11:03
Company registered at Companies House
